We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

G24:XETRScout24 SE Analysis

Data as of 2026-05-21 - not real-time

€70.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Scout24 delivered double‑digit revenue growth and an EBITDA margin now above 60%, underscoring its strong operating leverage. Gross margins remain in the mid‑70s percent range, while operating margins exceed 55%, highlighting efficient cost management. The company’s profitability is reinforced by a return on equity near 18%, indicating solid capital efficiency. The forward PE of roughly 15 suggests the stock trades below its growth‑adjusted peers, offering valuation upside. Current dividend yield around 2% with a payout ratio under 40% supports sustainability. Volume is on an upward trend, adding confidence to price moves.
Technical indicators show the price edging just above the 20‑day SMA, while the 50‑day SMA lies below, indicating a modest bullish bias. RSI sits near the midpoint, and MACD has turned slightly bearish, signaling mixed short‑term momentum. The 30‑day volatility exceeds 30%, reflecting a fairly volatile trading environment. Beta is low to mildly negative, implying limited market correlation. Overall, the blend of strong fundamentals, attractive valuation, and a reliable dividend makes the stock a compelling candidate for investors seeking both growth and income.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat with expanding margins
  • Mixed short‑term technical signals (bearish MACD histogram, neutral RSI)
  • Elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained double‑digit revenue growth
  • Undervalued forward PE relative to growth profile
  • Stable, sustainable dividend payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong market position in digital real‑estate marketplaces
  • High recurring revenue streams and expanding product suite
  • Robust cash generation potential supporting dividend growth

Key Metrics & Analysis

Financial Health

Revenue Growth14.00%
Profit Margin37.35%
P/E Ratio19.4
ROE17.66%
ROA9.29%
Debt/Equity25.21
P/B Ratio3.4
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI47.9
Support€67.15
Resistance€80.00
MA 20€71.12
MA 50€69.01
MA 200€87.43
MACDBearish
VolumeIncreasing
Fear & Greed Index91

Valuation

Target Price€103.13
Upside/Downside46.90%
GradeUndervalued
TypeBlend
Dividend Yield2.09%

Risk Assessment

Beta-0.19
Volatility39.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.